Regulus Therapeutics Inc.

General ticker "RGLS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $120.8M (TTM average)

Regulus Therapeutics Inc. follows the US Stock Market performance with the rate: 12.6%.

Estimated limits based on current volatility of 1.1%: low 8.00$, high 8.18$

Factors to consider:

  • Company does not operate outside North America (retrieved using AI)
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.14$, 3.08$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.74$, 2.13$]

Financial Metrics affecting the RGLS estimates:

  • Negative: Non-GAAP EPS, $ of -0.87 <= 0.05
  • Negative: Operating cash flow per share per price, % of -31.72 <= 1.99
  • Negative: Operating profit margin, % of -100 <= 0.04
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -24.73 <= 0
  • Negative: Shareholder equity ratio, % of 90.77 > 63.58
  • Negative: Industry operating profit margin (median), % of -98.39 <= 0.07
  • Negative: 0 < Interest expense per share, $ of 0
  • Negative: Investing cash flow per share, $ of -0.64 <= -0.10

Similar symbols

Short-term RGLS quotes

Long-term RGLS plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $28.24MM $31.11MM $50.04MM
Operating Income $-28.24MM $-31.11MM $-50.04MM
Non-Operating Income $-0.08MM $1.07MM $3.68MM
Interest Expense $0.69MM $0.60MM $0.16MM
R&D Expense $18.41MM $21.15MM $35.37MM
Income(Loss) $-28.32MM $-30.04MM $-46.36MM
Taxes $0.00MM $0.00MM $0.00MM
Profit(Loss)* $-28.32MM $-30.04MM $-46.36MM
Stockholders Equity $33.29MM $21.19MM $76.41MM
Inventory $0.00MM $3.01MM $0.00MM
Assets $46.72MM $30.75MM $84.18MM
Operating Cash Flow $-25.53MM $-26.77MM $-41.67MM
Capital expenditure $0.36MM $0.61MM $0.34MM
Investing Cash Flow $-15.12MM $14.49MM $-35.98MM
Financing Cash Flow $4.49MM $11.82MM $92.42MM
Earnings Per Share** $-1.86 $-1.58 $-0.82

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.